Estamos no ar no ! Saiba mais
ícone de BBC

Virtus Biotech Clinical Trials ETF

Nome Posição Valor negociado Ações
Variação
Variação na
participação
Royal Bank of Canada
1
Royal Bank of Canada
Ontario, Canada
US$ 3,54 mi +US$ 862 mil +31.709 +27%
Goldman Sachs
2
Goldman Sachs
New York
US$ 2,38 mi – – –
LPL Financial
3
LPL Financial
California
US$ 651 mil -US$ 470 mil -17.269 -39%
Jane Street
4
Jane Street
New York
US$ 642 mil +US$ 201 mil +7.409 +38%
Alpine Woods Capital Investors
5
Alpine Woods Capital Investors
New York
US$ 584 mil – – –
Citadel Advisors
6
Citadel Advisors
Florida
US$ 332 mil +US$ 159 mil +5.834 +72%
Morgan Stanley
7
Morgan Stanley
New York
US$ 214 mil +US$ 40,2 mil +1.480 +20%
Ladenburg Thalmann Financial Services
8
Ladenburg Thalmann Financial Services
Florida
US$ 12 mil -US$ 48,9 mil -1.800 -78%
UBS Group
9
UBS Group
Switzerland
US$ 6 mil -US$ 28,7 mil -1.055 -82%
Wells Fargo
10
Wells Fargo
California
US$ 5 mil -US$ 19,8 mil -729 -76%
Federation des caisses Desjardins du Quebec
11
Federation des caisses Desjardins du Quebec
Quebec, Canada
US$ 2,62 mil – – –
Stifel Financial
12
Stifel Financial
Missouri
– -US$ 317 mil -11.051 Encerrada
Bank of America
13
Bank of America
North Carolina
– -US$ 17 mil -590 Encerrada
Northwestern Mutual Wealth Management
14
Northwestern Mutual Wealth Management
Wisconsin
– -US$ 4 mil -150 Encerrada